• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉慢血流患者血浆血栓调节蛋白的评估

Evaluation of Plasma Thrombomodulin in Patients with Coronary Slow Flow.

作者信息

Wang Yong, Jia Peng-Yu, Chen Bao-Jun, Chen Yan, Yu Hang, Yu Yao, Yang Hui-Min, Jia Da-Lin, Ma Chun-Yan

机构信息

Department of Cardiology, The People's Hospital of China Medical University, The People's Hospital of Liaoning Province, Shenyang, China.

出版信息

Cardiology. 2017;138(3):141-146. doi: 10.1159/000460239. Epub 2017 Jun 27.

DOI:10.1159/000460239
PMID:28651248
Abstract

BACKGROUND

It has been reported that coronary slow flow (CSF) is associated with acute myocardial infarction, ventricular tachycardia, ventricular fibrillation, and even sudden cardiac death. Although studies concerning the etiopathogenesis of CSF are scarce, diffuse atherosclerosis and endothelial dysfunction are thought to play important roles. It has been suggested that a high plasma thrombomodulin (TM) level seems to play an important role in the pathogenesis of atherosclerosis and endothelial dysfunction.

OBJECTIVES

We hypothesized that a high plasma TM level might be associated with CSF and aimed to research the relationship between plasma TM level and CSF.

METHODS

Fifty-two CSF patients with angiographically proven CSF and 44 cases with normal coronary flow were included in this study. Coronary flow velocity was determined by the thrombolysis in myocardial infarction (TIMI) frame count method. Plasma TM levels were measured in all the study subjects.

RESULTS

Plasma TM levels were significantly higher in the CSF group compared to the control group (3.9 ± 0.5 vs. 3.6 ± 0.3 ng/mL, p = 0.01). There was a positive relationship (r = 0.31, p = 0.002) between plasma TM level and mean TIMI frame count (TFC). Factors associated with mean TFC were plasma TM level (β = 0.206, p = 0.038) and red cell distribution width (β = 0.088, p = 0.009) in multiple linear regression analysis.

CONCLUSIONS

Patients with CSF have a higher plasma TM level, and this may play an important role in the pathogenesis of CSF. An elevated plasma TM level may be a predictor of CSF. Future studies are needed to confirm these results.

摘要

背景

据报道,冠状动脉慢血流(CSF)与急性心肌梗死、室性心动过速、心室颤动甚至心源性猝死相关。尽管关于CSF病因发病机制的研究较少,但弥漫性动脉粥样硬化和内皮功能障碍被认为起重要作用。有人提出,高血浆血栓调节蛋白(TM)水平似乎在动脉粥样硬化和内皮功能障碍的发病机制中起重要作用。

目的

我们假设高血浆TM水平可能与CSF有关,并旨在研究血浆TM水平与CSF之间的关系。

方法

本研究纳入了52例经血管造影证实为CSF的患者和44例冠状动脉血流正常的患者。采用心肌梗死溶栓(TIMI)帧数法测定冠状动脉血流速度。在所有研究对象中测量血浆TM水平。

结果

与对照组相比,CSF组的血浆TM水平显著更高(3.9±0.5 vs. 3.6±0.3 ng/mL,p = 0.01)。血浆TM水平与平均TIMI帧数(TFC)之间存在正相关关系(r = 0.31,p = 0.002)。在多元线性回归分析中,与平均TFC相关的因素是血浆TM水平(β = 0.206,p = 0.038)和红细胞分布宽度(β = 0.088,p = 0.009)。

结论

CSF患者的血浆TM水平较高,这可能在CSF的发病机制中起重要作用。血浆TM水平升高可能是CSF的一个预测指标。需要进一步的研究来证实这些结果。

相似文献

1
Evaluation of Plasma Thrombomodulin in Patients with Coronary Slow Flow.冠状动脉慢血流患者血浆血栓调节蛋白的评估
Cardiology. 2017;138(3):141-146. doi: 10.1159/000460239. Epub 2017 Jun 27.
2
Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.血浆同型半胱氨酸与甲状腺激素浓度在冠状动脉血流缓慢现象发病机制中的相互作用。
Cardiology. 2007;108(3):186-92. doi: 10.1159/000096687. Epub 2006 Nov 3.
3
Elevated level of plasma homocysteine in patients with slow coronary flow.冠状动脉血流缓慢患者血浆同型半胱氨酸水平升高。
Int J Cardiol. 2005 Jul 20;102(3):419-23. doi: 10.1016/j.ijcard.2004.05.064.
4
The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.冠状动脉慢血流现象与尾加压素 -II 的关系:一项前瞻性对照研究。
Anatol J Cardiol. 2015 Jun;15(6):475-9. doi: 10.5152/akd.2014.5481. Epub 2014 Apr 28.
5
Assessment of risk factors and left ventricular function in patients with slow coronary flow.冠状动脉血流缓慢患者的危险因素及左心室功能评估
Heart Vessels. 2016 Mar;31(3):288-97. doi: 10.1007/s00380-014-0606-4. Epub 2014 Dec 5.
6
Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation.经 TIMI 帧数法记录的房颤患者冠脉血流受损情况。
Int J Cardiol. 2013 Aug 20;167(4):1176-80. doi: 10.1016/j.ijcard.2012.03.118. Epub 2012 Apr 5.
7
The effects of endothelial dysfunction and inflammation on slow coronary flow.内皮功能障碍和炎症对冠状动脉血流缓慢的影响。
Turk Kardiyol Dern Ars. 2010 Jul;38(5):327-33.
8
The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries.冠状动脉正常患者的冠状动脉血流速率、血浆内皮素-1浓度与临床特征之间的关系。
Cardiovasc Revasc Med. 2008 Jul-Sep;9(3):144-8. doi: 10.1016/j.carrev.2007.11.002.
9
Assessment of coronary blood flow in hypertrophic cardiomyopathy using thrombolysis in myocardial infarction frame count method.使用心肌梗死溶栓帧数法评估肥厚型心肌病患者的冠状动脉血流
J Invasive Cardiol. 2005 Feb;17(2):73-6.
10
Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.冠状动脉血流缓慢患者血浆可溶性黏附分子ICAM-1、VCAM-1和E-选择素水平升高。
Int J Cardiol. 2006 Apr 4;108(2):224-30. doi: 10.1016/j.ijcard.2005.05.008. Epub 2005 Jul 5.

引用本文的文献

1
Advanced Lung Cancer Inflammation Index as a Predictor of Coronary Slow Flow Phenomenon in Patients with Angina and Non-Obstructive Coronary Arteries.晚期肺癌炎症指数作为心绞痛和非阻塞性冠状动脉患者冠状动脉慢血流现象的预测指标
Int J Gen Med. 2025 May 9;18:2497-2505. doi: 10.2147/IJGM.S522261. eCollection 2025.
2
Association Between the Aggregate Index of Systemic Inflammation and Slow Coronary Flow Phenomenon in Patients with Ischemia and No Obstructive Coronary Arteries.无阻塞性冠状动脉疾病的缺血患者全身炎症综合指数与冠状动脉血流缓慢现象之间的关联
Int J Gen Med. 2025 Mar 12;18:1431-1438. doi: 10.2147/IJGM.S515822. eCollection 2025.
3
Correlation between admission blood glucose, fibrinogen, and slow blood flow during primary PCI for acute ST segment elevation myocardial infarction.
急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗时入院血糖、纤维蛋白原与血流缓慢之间的相关性
Front Cardiovasc Med. 2024 Dec 3;11:1478743. doi: 10.3389/fcvm.2024.1478743. eCollection 2024.
4
Association between inflammatory burden index and coronary slow flow phenomenon in patients with chest pain and no obstructive coronary arteries.炎症负担指数与胸痛且无阻塞性冠状动脉病变患者冠状动脉慢血流现象的相关性。
BMC Cardiovasc Disord. 2024 Oct 26;24(1):595. doi: 10.1186/s12872-024-04281-4.
5
Association Between Systemic Inflammation Response Index and Slow Coronary Flow Phenomenon in Patients with Ischemia and No Obstructive Coronary Arteries.无阻塞性冠状动脉疾病的缺血性患者全身炎症反应指数与冠状动脉血流缓慢现象之间的关联
Int J Gen Med. 2024 Sep 13;17:4045-4053. doi: 10.2147/IJGM.S481538. eCollection 2024.
6
Neutrophil Percentage to Albumin Ratio as a Predictor for Coronary Slow Flow Phenomenon in Patients with Myocardial Ischemia with No Obstructive Coronary Arteries.中性粒细胞百分比与白蛋白比值作为无阻塞性冠状动脉心肌缺血患者冠状动脉慢血流现象的预测指标
Int J Gen Med. 2024 Aug 14;17:3511-3519. doi: 10.2147/IJGM.S477431. eCollection 2024.
7
Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries.尿酸与白蛋白比值作为慢性冠状动脉综合征伴非阻塞性冠状动脉疾病患者冠状动脉慢血流现象的新型预测因子。
BMC Cardiovasc Disord. 2024 Jul 13;24(1):358. doi: 10.1186/s12872-024-04040-5.
8
Critical role of the coronary microvasculature in heart disease: From pathologic driving force to "innocent" bystander.冠状动脉微血管在心脏病中的关键作用:从病理驱动力到“无辜”旁观者
Am Heart J Plus. 2022 Oct 1;22:100215. doi: 10.1016/j.ahjo.2022.100215. eCollection 2022 Oct.
9
Triglyceride glucose-body mass index as a novel predictor of slow coronary flow phenomenon in patients with ischemia and nonobstructive coronary arteries (INOCA).三酰甘油-葡萄糖-体重指数作为缺血伴非阻塞性冠状动脉疾病(INOCA)患者慢血流现象的新预测因子。
BMC Cardiovasc Disord. 2024 Jan 19;24(1):60. doi: 10.1186/s12872-024-03722-4.
10
Assessment of the relationship between plasma fibrinogen-to-albumin ratio and slow coronary flow phenomenon in patients without obstructive coronary artery disease.评估无阻塞性冠状动脉疾病患者血浆纤维蛋白原-白蛋白比值与慢血流现象之间的关系。
BMC Cardiovasc Disord. 2023 Nov 6;23(1):540. doi: 10.1186/s12872-023-03579-z.